Publications by authors named "Brea Lipe"

Claim this Profile
I
Infections and parameters of humoral immunity with talquetamab in relapsed/refractory multiple myeloma in MonumenTAL-1.
Carolina Schinke, Paula Rodriguez-Otero, Niels W C J van de Donk, Brea Lipe, Noa Lavi

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of Ciltacabtagene Autoleucel in CARTITUDE-4 Versus Real-World Physician's Choice of Therapy from the Flatiron Registry in Lenalidomide-Refractory Multiple Myeloma.
Cyrille Touzeau, Brea Lipe, Abdullah M Khan, Binod Dhakal, Sandhya Nair

Adv Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and Management of Cytokine Release Syndrome From the MonumenTAL-1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma.
Niels W C J van de Donk, Ajai Chari, Thomas Martin, Amrita Krishnan, Leo Rasche, Brea Lipe

Cancer Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Efficacy of Ciltacabtagene Autoleucel Versus Standard-of-Care Treatments for Patients with Previously Treated Relapsed or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Comparison.
Noemi Puig, Joris Diels, Suzy van Sanden, João Mendes, Heather Burnett, Brea Lipe

Adv Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1-2 study.
Ajai Chari, Cyrille Touzeau, Carolina Schinke, Monique C Minnema, Jesus G Berdeja, Brea Lipe

Lancet Haematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma.
Andrew J Yee, Jacob P Laubach, Erica L Campagnaro, Brea C Lipe, Omar Nadeem

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab.
Ajai Chari, Amrita Krishnan, Leo Rasche, Jing Christine Ye, Alfred Garfall, Brea Lipe

Clin Lymphoma Myeloma Leuk· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Treatment of Multiple Myeloma in Frail Patients.
Jodi J Lipof, Nadine Abdallah, Brea Lipe

Curr Oncol Rep· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies.
Gary J Schiller, Brea C Lipe, Nizar J Bahlis, Sascha A Tuchman, William I Bensinger

Clin Lymphoma Myeloma Leuk· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Siltuximab as a primary treatment for cytokine release syndrome in a patient receiving a bispecific antibody in a clinical trial setting.
Brea C Lipe, Thomas Renaud

J Oncol Pharm Pract· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies.
Hengwei Zhang, Jane L Liesveld, Laura M Calvi, Brea C Lipe, Lianping Xing

Bone Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onychomadesis and palmoplantar keratoderma associated with talquetamab therapy for relapsed and refractory multiple myeloma.
Neha Narayan, Benjamin Williams, Brea Lipe, Anna De Benedetto

JAAD Case Rep· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatment.
Muhamed Baljevic, Cristina Gasparetto, Gary J Schiller, Sascha A Tuchman, Natalie S Callander, Brea Lipe

EJHaem· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laboratory Detection and Initial Diagnosis of Monoclonal Gammopathies.
David F Keren, Gregary Bocsi, Brooke L Billman, Joan Etzell, James D Faix, Brea Lipe

Arch Pathol Lab Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOHO State of the Art Updates and Next Questions: Treatment of Older, Vulnerable Adults with Multiple Myeloma.
Shakira J Grant, Girija Joshi, Brea Lipe

Clin Lymphoma Myeloma Leuk· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-free DNA for the detection of emerging treatment failure in relapsed/ refractory multiple myeloma.
Johannes M Waldschmidt, Andrew J Yee, Tushara Vijaykumar, Ricardo A Pinto, Julia Frede, Brea Lipe

Leukemia· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients.
Cristina Gasparetto, Gary J Schiller, Sascha A Tuchman, Natalie S Callander, Muhamed Baljevic, Brea Lipe

Br J Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group.
Noopur S Raje, Elias Anaissie, Shaji K Kumar, Sagar Lonial, Thomas Martin, Brea Lipe

Lancet Haematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bisphosphonates for delivering drugs to bone.
Shuting Sun, Jianguo Tao, Parish P Sedghizadeh, Philip Cherian, Adam F Junka, Brea Lipe

Br J Pharmacol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma.
Cristina Gasparetto, Suzanne Lentzsch, Gary Schiller, Natalie Callander, Sascha Tuchman, Brea Lipe

EJHaem· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial.
Saad Z Usmani, Antje Hoering, Sikander Ailawadhi, Rachael Sexton, Brea Lipe

Lancet Haematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Frail Older Adults with Newly Diagnosed Multiple Myeloma - Moving Toward a Personalized Approach.
Shakira J Grant, Brea Lipe

Clin Lymphoma Myeloma Leuk· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Touchscreen-Based Geriatric Assessment and Frailty Screening for Adults With Multiple Myeloma to Drive Personalized Treatment Decisions.
Nitya Nathwani, Sandra E Kurtin, Brea Lipe, Supriya Gupta Mohile, Donna D Catamero

JCO Oncol Pract· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of thrombotic microangiopathies in multiple myeloma.
Andrew Jay Portuguese, Conrad Gleber, Frank C Passero, Brea Lipe

Leuk Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of the First Clinical Study in Humans That Combines Hyperbaric Oxygen Pretreatment with Autologous Peripheral Blood Stem Cell Transplantation.
Haitham Abdelhakim, Leyla Shune, Sajjad Bhatti, Amy Rose Cantilena, Andrea Baran, Brea Lipe

Biol Blood Marrow Transplant· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis